Combinations of SAP depleting agents and anti-SAP antibodies
US7910106B2 · kind B2 · utility
1Cited by
0References
42Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 30, 2008 |
| Grant date | Mar 22, 2011 |
| Priority date | — |
| Expiry date | Dec 30, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes the use of an antibody specific for serum amyloid P component, for the treatment or prophylaxis of amyloidosis, and the use of a compound which depletes serum amyloid P component from the circulation in combination with an antibody specific for serum amyloid P component.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.